Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$128,839
+$17,485 QoQ
Shares Held
512
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#4,003
of 4,152 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MRP Capital Investments, LLC holds $6,725,014 across 7 Drug Manufacturers - General names. ABBV ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,932 | $3,516,728 | |
| 2 | JNJ |
Johnson & Johnson
|
6,201 | $1,574,867 | |
| 3 | PFE |
Pfizer Inc
|
47,847 | $1,152,155 | |
| 4 | AMGN |
Amgen Inc
|
650 | $235,378 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
512 | $128,839 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
900 | $113,706 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
58 | $3,341 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,839 | 512 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $111,354 | 512 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $116,986 | 512 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $130,125 | 562 | Shares | Sole | 2025-12-08 | |
| 2025-06-30 | $104,318 | 562 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $117,750 | 562 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $99,867 | 562 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $110,983 | 562 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $89,191 | 662 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $105,502 | 662 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $414,852 | 2,567 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||